Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.
| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 40876 | Czechia – Cereals – Dodávky osiv zemědělských plodin (DNS) Buyer: Lesy České republiky, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-01-04 | Tender Procurement Contract | Czechia | Not provided on the source page. Please check the official source. | Open Jan 4, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Lesy České republiky, s.p. | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-01-04 |
||||||
| 40877 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40878 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40879 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Nilotinib, ATC L01EA03 (ausgeschlossen Nilotinib dispergiert in Apfelmus, es sei denn, der Hersteller genießt hierfür Patentschutz) Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40880 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40881 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Botulinumtoxin Typ A, Fertigarzneimittelbezeichnung Xeomin(R), ATC M03AX21 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40882 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Goserelin, ATC L02AE03 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40883 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40884 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Telmisartan + Amlodipin, (OBG) ATC C09DB04 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40885 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nebivolol, (OBG) ATC C07AB12 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40886 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Progesteron ausschließlich Darreichungsform VKA, (OBO) ATC G03DA04 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40887 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Colecalciferol, non RX, ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte, ATC A11CC05 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40888 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Elbasvir + Grazoprevir, (OBO) ATC J05AP54 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40889 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nitisinon, (OBO) ATC A16AX04 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40890 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, (OBG) ATC L04AC05 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40891 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, (OBO) ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40892 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bempedoinsäure + Ezetimib, (OBO) ATC C10BA10 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40893 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40894 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Atovaquon, (OBG) ATC P01AX06 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40895 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim,(OBO) ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40896 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bempedoinsäure, (OBO) ATC C10AX15 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40897 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam, (OBG) ATC N05BA09 für die Zeit 01.03.2025 - 28.02.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Jan 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-01-05 |
||||||
| 40898 | Czechia – Lifts – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA POŘÍZENÍ NOVÝCH VÝTAHŮ Buyer: Všeobecná fakultní nemocnice v Praze | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 20... | Tender Procurement Contract | Czechia | Not provided on the source page. Please check the official source. | Open Jan 6, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Všeobecná fakultní nemocnice v Praze | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-01-06 |
||||||
| 40899 | Slovenia – Engineering services – Izvedba recenzij s področja gradbeništva, elektrotehnike, strojništva in s področja požarne varnosti za infrastrukturne projekte Buyer: DRI upravljanje investicij, Družba za razvoj infrastrukture, d.o.o. | Notice type: cn-standard | Procedure: restricted | Co... | Tender Procurement Contract | Slovenia | Not provided on the source page. Please check the official source. | Open Jan 7, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DRI upravljanje investicij, Družba za razvoj infrastrukture, d.o.o. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-01-07 |
||||||
| 40900 | Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale re... | Grant Cash Grant | United States | Award ceiling: $375,000 | Open Jan 7, 2027 Open | Grants.gov |
|
Source description
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm. |
||||||
